Actos Bladder Cancer :There is a very close relationship between survival of an individual and the stage of bladder cancer at diagnosis. For superficial disease, five year survival rates are greater than 90%. Once the cancer has spread into the bladder muscle and beyond, survival is markedly reduced. Five year survival in those with T2 disease [...]
Actos Bladder Cancer : Ureteral-Ileal anastomotic stenosis: The ureters are carefully attached to the base of the ileal loop. Stents are placed at the time of surgery to allow the connection to heal in an open fashion. Nevertheless, the ureteral anastomosis may scar over time, leading to blockage of the ureter and its respective kidney. The [...]
Actos Bladder Cancer : Within treatment trials, there are four categories, or phases. You’ll want to ask the members of your medical team which phase of clinical trial they are recommending to you and find out specific details such as the number of people involved, where the testing is being done, what benefits/drawbacks are expected for you [...]
Actos Bladder Cancer : Chemotherapy is offered most often in the face of metastatic disease or advanced local disease that cannot be removed surgically. Chemotherapy in this setting can result in complete response (disappearance of all visible tumors) in approximately 20% of patients. For these individuals, success of therapy can be monitored with imaging studies such as [...]
Actos Bladder Cancer : In Europe, chemotherapy drugs like mitomycin C, doxorubicin, epirubicin, and valrubicin are commonly used as first-line intravesical therapy. These agents are not considered first line in the United States because several studies have shown improved effectiveness with BCG compared to these drugs. Furthermore, unlike BCG, which decreases the risk of cancer progression [...]
Actos Bladder Cancer :There is a very close relationship between survival of an individual and the stage of bladder cancer at diagnosis. For superficial disease, five year survival rates are greater than 90%. Once the cancer has spread into the bladder muscle and beyond, survival is markedly reduced. Five year survival in those with T2 disease [...]
Actos Bladder Cancer : Ureteral-Ileal anastomotic stenosis: The ureters are carefully attached to the base of the ileal loop. Stents are placed at the time of surgery to allow the connection to heal in an open fashion. Nevertheless, the ureteral anastomosis may scar over time, leading to blockage of the ureter and its respective kidney. The [...]
Actos Bladder Cancer : Within treatment trials, there are four categories, or phases. You’ll want to ask the members of your medical team which phase of clinical trial they are recommending to you and find out specific details such as the number of people involved, where the testing is being done, what benefits/drawbacks are expected for you [...]
Actos Bladder Cancer : Chemotherapy is offered most often in the face of metastatic disease or advanced local disease that cannot be removed surgically. Chemotherapy in this setting can result in complete response (disappearance of all visible tumors) in approximately 20% of patients. For these individuals, success of therapy can be monitored with imaging studies such as [...]
Actos Bladder Cancer : In Europe, chemotherapy drugs like mitomycin C, doxorubicin, epirubicin, and valrubicin are commonly used as first-line intravesical therapy. These agents are not considered first line in the United States because several studies have shown improved effectiveness with BCG compared to these drugs. Furthermore, unlike BCG, which decreases the risk of cancer progression [...]